Should we fear stagflation?
Stagflation – a toxic mixture of weak growth plus inflation – is rearing its ugly head again. Can we avoid it?


Ever since coronavirus vaccines arrived on the scene more rapidly than expected last year, the hope has been that economies could re-open quickly, households flush with savings would go out and spend, and we’d see a resurgence in growth to match the slide seen during global lockdowns. In the stockmarket, this particular bet was known as the “reflation” trade, with the companies hardest hit by lockdowns rebounding, while other “value” stocks such as miners benefited from surging demand for resources.
However, while growth has rebounded at a rapid pace, there are signs that the recovery might be running out of steam. The latest US nonfarm payrolls figures (a monthly measure of how many jobs are being added to the US economy) was hugely disappointing. And it’s just the latest sign that the Delta variant has thrown a spanner in the works of the re-opening process. As a result, we’re seeing more and more talk of an economic spectre that hasn’t reared its ugly head in 50 years – stagflation.
Stagflation (“stagnation” plus “inflation”) is an unusual and unpleasant condition in which the economy grows slowly or falls into recession, yet inflation stays high and rising. This makes it a central bank’s worst nightmare – they can’t raise interest rates to tackle inflation without squeezing the weak economy further, but they can’t cut rates to try to boost growth without fuelling inflation.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
So is it on the cards? We have argued for some time that we’re moving into a more inflationary world. But we’d hope that this would be combined with strong growth for at least a while. The main risk right now probably stems from any stalling in the re-opening process and employees returning to work. If that happens then activity and growth will take a hit, but supply chain issues will only get worse, partly due to labour market disruption. As Nouriel Roubini argued on Project Syndicate recently, we’re already seeing “mild” stagflation. The misery index (defined below) is running at double-digit levels due to high inflation and still-stubbornly high unemployment, levels not seen persistently since the late 1970s.
One thing is clear – investors should hope we can avoid it. Stagflation is mostly associated with the 1970s oil shocks, but Mark Hulbert in The Wall Street Journal notes that the stagflationary period actually ran from 1966 through to 1982, when then-US Federal Reserve head Paul Volcker helped to kill it off – at the cost of a huge recession – by raising US interest rates to double-digit levels. In that period, US stocks made almost nothing in “real” terms (ie after inflation), bond investors had to be very selective (avoiding long duration bonds in favour of medium and short-term ones), and even commodities – the classic inflation hedge – were mixed. Keep watching the jobs market.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
John Stepek is a senior reporter at Bloomberg News and a former editor of MoneyWeek magazine. He graduated from Strathclyde University with a degree in psychology in 1996 and has always been fascinated by the gap between the way the market works in theory and the way it works in practice, and by how our deep-rooted instincts work against our best interests as investors.
He started out in journalism by writing articles about the specific business challenges facing family firms. In 2003, he took a job on the finance desk of Teletext, where he spent two years covering the markets and breaking financial news.
His work has been published in Families in Business, Shares magazine, Spear's Magazine, The Sunday Times, and The Spectator among others. He has also appeared as an expert commentator on BBC Radio 4's Today programme, BBC Radio Scotland, Newsnight, Daily Politics and Bloomberg. His first book, on contrarian investing, The Sceptical Investor, was released in March 2019. You can follow John on Twitter at @john_stepek.
-
David Ellison: America's new media mogul
David Ellison is building a mighty new force in old and new media. Critics worry that he will prove to be a Trumpian patsy. Is that fair?
-
Investors have overlooked some of China’s best growth stocks
Opinion Dale Nicholls, portfolio manager, Fidelity China Special Situations, highlights three Chinese businesses where he’d put his money
-
David Ellison: America's new media mogul
David Ellison is building a mighty new force in old and new media. Critics worry that he will prove to be a Trumpian patsy. Is that fair?
-
How Next defied the odds and positioned itself as a British high-street staple
Next rose from a near-death experience and now thrives as a high-street staple. What's driving its success – and should you invest in the retailer?
-
Why investors should avoid market monomania
Opinion Today’s overwhelming focus on US markets leaves investors guessing about opportunities and risks elsewhere
-
Can Rachel Reeves save the City?
Opinion Chancellor Rachel Reeves is mulling a tax cut, which would be welcome – but it’s nowhere near enough, says Matthew Lynn
-
Global investors have overlooked the top innovators in emerging markets
Opinion Carlos Hardenberg, portfolio manager, Mobius Investment Trust, highlights three emerging market stocks where he’d put his money
-
Investors should cheer the coming nuclear summer
The US and UK have agreed a groundbreaking deal on nuclear power, and the sector is seeing a surge in interest from around the world. Here's how you can profit
-
Healthcare stocks look cheap, but tread carefully
Shares in healthcare companies could get a shot in the arm if uncertainty over policy in the US wanes, but are they worth the risk?
-
The Palace of Westminster is falling down
The Palace of Westminster is in need of repair, but the bill is prohibitive, says Simon Wilson